vs

Side-by-side financial comparison of JBT Marel Corp (JBTM) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

JBT Marel Corp is the larger business by last-quarter revenue ($1.0B vs $665.5M, roughly 1.5× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs 5.3%, a 1.8% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 39.8%). JBT Marel Corp produced more free cash flow last quarter ($83.5M vs $37.8M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 34.5%).

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

JBTM vs NTRA — Head-to-Head

Bigger by revenue
JBTM
JBTM
1.5× larger
JBTM
$1.0B
$665.5M
NTRA
Growing faster (revenue YoY)
JBTM
JBTM
+75.8% gap
JBTM
115.6%
39.8%
NTRA
Higher net margin
NTRA
NTRA
1.8% more per $
NTRA
7.1%
5.3%
JBTM
More free cash flow
JBTM
JBTM
$45.7M more FCF
JBTM
$83.5M
$37.8M
NTRA
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
34.5%
NTRA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
JBTM
JBTM
NTRA
NTRA
Revenue
$1.0B
$665.5M
Net Profit
$53.1M
$47.3M
Gross Margin
34.5%
Operating Margin
7.2%
-3.4%
Net Margin
5.3%
7.1%
Revenue YoY
115.6%
39.8%
Net Profit YoY
858.6%
187.9%
EPS (diluted)
$1.04
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JBTM
JBTM
NTRA
NTRA
Q4 25
$1.0B
$665.5M
Q3 25
$1.0B
$592.2M
Q2 25
$934.8M
$546.6M
Q1 25
$854.1M
$501.8M
Q4 24
$467.6M
$476.1M
Q3 24
$453.8M
$439.8M
Q2 24
$402.3M
$413.4M
Q1 24
$392.3M
$367.7M
Net Profit
JBTM
JBTM
NTRA
NTRA
Q4 25
$53.1M
$47.3M
Q3 25
$66.0M
$-87.5M
Q2 25
$3.4M
$-100.9M
Q1 25
$-173.0M
$-66.9M
Q4 24
$-7.0M
$-53.8M
Q3 24
$38.9M
$-31.6M
Q2 24
$30.7M
$-37.5M
Q1 24
$22.8M
$-67.6M
Gross Margin
JBTM
JBTM
NTRA
NTRA
Q4 25
34.5%
Q3 25
35.9%
Q2 25
35.8%
Q1 25
34.2%
Q4 24
38.4%
Q3 24
36.1%
Q2 24
35.6%
Q1 24
35.8%
Operating Margin
JBTM
JBTM
NTRA
NTRA
Q4 25
7.2%
-3.4%
Q3 25
10.2%
-16.5%
Q2 25
5.2%
-20.2%
Q1 25
-3.9%
-15.8%
Q4 24
3.4%
-13.6%
Q3 24
10.3%
-8.9%
Q2 24
6.7%
-10.6%
Q1 24
7.4%
-20.2%
Net Margin
JBTM
JBTM
NTRA
NTRA
Q4 25
5.3%
7.1%
Q3 25
6.6%
-14.8%
Q2 25
0.4%
-18.5%
Q1 25
-20.3%
-13.3%
Q4 24
-1.5%
-11.3%
Q3 24
8.6%
-7.2%
Q2 24
7.6%
-9.1%
Q1 24
5.8%
-18.4%
EPS (diluted)
JBTM
JBTM
NTRA
NTRA
Q4 25
$1.04
$0.36
Q3 25
$1.26
$-0.64
Q2 25
$0.07
$-0.74
Q1 25
$-3.35
$-0.50
Q4 24
$-0.22
$-0.41
Q3 24
$1.21
$-0.26
Q2 24
$0.95
$-0.30
Q1 24
$0.71
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JBTM
JBTM
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$167.9M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$4.5B
$1.7B
Total Assets
$8.2B
$2.4B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JBTM
JBTM
NTRA
NTRA
Q4 25
$167.9M
Q3 25
$1.0M
Q2 25
$16.0M
Q1 25
$17.8M
Q4 24
$1.2B
$22.7M
Q3 24
$29.5M
Q2 24
$90.3M
Q1 24
$69.1M
Total Debt
JBTM
JBTM
NTRA
NTRA
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$2.0B
Q4 24
$1.3B
Q3 24
$648.3M
Q2 24
$647.7M
Q1 24
$647.0M
Stockholders' Equity
JBTM
JBTM
NTRA
NTRA
Q4 25
$4.5B
$1.7B
Q3 25
$4.4B
$1.3B
Q2 25
$4.4B
$1.2B
Q1 25
$4.1B
$1.2B
Q4 24
$1.5B
$1.2B
Q3 24
$1.6B
$878.5M
Q2 24
$1.5B
$836.5M
Q1 24
$1.5B
$794.1M
Total Assets
JBTM
JBTM
NTRA
NTRA
Q4 25
$8.2B
$2.4B
Q3 25
$8.2B
$1.8B
Q2 25
$8.3B
$1.8B
Q1 25
$8.0B
$1.7B
Q4 24
$3.4B
$1.7B
Q3 24
$2.8B
$1.6B
Q2 24
$2.7B
$1.5B
Q1 24
$2.7B
$1.5B
Debt / Equity
JBTM
JBTM
NTRA
NTRA
Q4 25
0.33×
Q3 25
0.34×
Q2 25
0.35×
Q1 25
0.48×
Q4 24
0.81×
Q3 24
0.41×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JBTM
JBTM
NTRA
NTRA
Operating Cash FlowLast quarter
$117.4M
$73.9M
Free Cash FlowOCF − Capex
$83.5M
$37.8M
FCF MarginFCF / Revenue
8.3%
5.7%
Capex IntensityCapex / Revenue
3.4%
5.4%
Cash ConversionOCF / Net Profit
2.21×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$238.1M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JBTM
JBTM
NTRA
NTRA
Q4 25
$117.4M
$73.9M
Q3 25
$87.7M
$59.4M
Q2 25
$102.2M
$37.6M
Q1 25
$34.4M
$44.5M
Q4 24
$128.7M
$52.9M
Q3 24
$71.9M
$51.8M
Q2 24
$21.6M
$4.0M
Q1 24
$10.4M
$27.0M
Free Cash Flow
JBTM
JBTM
NTRA
NTRA
Q4 25
$83.5M
$37.8M
Q3 25
$56.5M
$37.0M
Q2 25
$83.7M
$11.7M
Q1 25
$14.4M
$22.6M
Q4 24
$118.7M
$34.8M
Q3 24
$65.0M
$35.5M
Q2 24
$11.1M
$-7.7M
Q1 24
$-100.0K
$6.7M
FCF Margin
JBTM
JBTM
NTRA
NTRA
Q4 25
8.3%
5.7%
Q3 25
5.6%
6.2%
Q2 25
9.0%
2.1%
Q1 25
1.7%
4.5%
Q4 24
25.4%
7.3%
Q3 24
14.3%
8.1%
Q2 24
2.8%
-1.9%
Q1 24
-0.0%
1.8%
Capex Intensity
JBTM
JBTM
NTRA
NTRA
Q4 25
3.4%
5.4%
Q3 25
3.1%
3.8%
Q2 25
2.0%
4.7%
Q1 25
2.3%
4.3%
Q4 24
2.1%
3.8%
Q3 24
1.5%
3.7%
Q2 24
2.6%
2.8%
Q1 24
2.7%
5.5%
Cash Conversion
JBTM
JBTM
NTRA
NTRA
Q4 25
2.21×
1.56×
Q3 25
1.33×
Q2 25
30.06×
Q1 25
Q4 24
Q3 24
1.85×
Q2 24
0.70×
Q1 24
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons